BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7942792)

  • 1. Increased glutathione in chronic lymphocytic leukemia lymphocytes.
    Ferraris AM; Rolfo M; Mangerini R; Gaetani GF
    Am J Hematol; 1994 Nov; 47(3):237-8. PubMed ID: 7942792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione depletion in chronic lymphocytic leukemia B lymphocytes.
    Silber R; Farber CM; Papadopoulos E; Nevrla D; Liebes L; Bruck M; Brown R; Canellakis ZN
    Blood; 1992 Oct; 80(8):2038-43. PubMed ID: 1356514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia.
    Bakan N; Taysi S; Yilmaz O; Bakan E; Kuşkay S; Uzun N; Gündoğdu M
    Clin Chim Acta; 2003 Dec; 338(1-2):143-9. PubMed ID: 14637279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
    Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
    Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance mechanisms in chronic lymphocytic leukemia.
    Ribrag V; Massade L; Faussat AM; Dreyfus F; Bayle C; Gouyette A; Marie JP
    Leukemia; 1996 Dec; 10(12):1944-9. PubMed ID: 8946935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress accelerates spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes.
    Djurdjevic P; Zelen I; Ristic P; Jovanovic I; Jakovljevic V; Baskic D; Popovic S; Arsenijevic N
    J BUON; 2009; 14(2):281-7. PubMed ID: 19650179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
    Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
    Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
    Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC
    Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular IFN-gamma expression by CD3+/CD8+ cell subset in B-CLL patients correlates with stage of the disease.
    Podhorecka M; Dmoszynska A; Rolinski J
    Eur J Haematol; 2004 Jul; 73(1):29-35. PubMed ID: 15182335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: How much do we actually know?
    Galicia-Vázquez G; Aloyz R
    Crit Rev Oncol Hematol; 2019 Feb; 134():65-70. PubMed ID: 30771875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
    Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytic clusters in peripheral blood: an atypical morphologic pattern of chronic lymphocytic leukemia.
    Bizzaro N; Piazza I
    Acta Haematol; 1991; 86(4):209-11. PubMed ID: 1805489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant enzymes in lymphocytes from normal subjects and patients with chronic lymphocytic leukaemia: increased glutathione peroxidase activity in CLL B lymphocytes.
    Farber CM; Kanganis DN; Liebes LF; Silber R
    Br J Haematol; 1989 May; 72(1):32-5. PubMed ID: 2786733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased deformability of lymphocytes in chronic lymphocytic leukemia.
    Zheng Y; Wen J; Nguyen J; Cachia MA; Wang C; Sun Y
    Sci Rep; 2015 Jan; 5():7613. PubMed ID: 25573422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood lymphocyte phenotype of ZAP-70⁺ and ZAP-70⁻ patients with B-cell chronic lymphocytic leukaemia.
    Rivkina A; Holodnuka-Kholodyuk I; Murovska M; Soloveichika M; Lejniece S
    Exp Oncol; 2015 Mar; 37(1):73-6. PubMed ID: 25804237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms.
    Zhang W; Pelicano H; Yin R; Zeng J; Wen T; Ding L; Huang R
    Mol Med Rep; 2015 Nov; 12(5):7374-88. PubMed ID: 26458979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia with prostate infiltration mediated by specific clonal membrane-bound IgM.
    Bogdan CA; Alexander AA; Gorny MK; Matute R; Marjanovic N; Zolla-Pazner S; Walden PD; Furneaux HM; Sidhu GS; Jacobson DR
    Cancer Res; 2003 May; 63(9):2067-71. PubMed ID: 12727821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.